Pharmiva is an innovation driven company with a focus on diseases related to women’s health. We develop and market products based on a unique expert knowledge within research and development of medical products aimed for local administration.
Last update: annual meeting of shareholders 16th June 2020
| GÅL Pharma AB (founders and management) | 12,59% |
| Indavvio AB (founders and management) | 12,29% |
| Venture Holdings AB (founders and management) | 7,18% |
| Prolajm AB (management) | 6,14% |
| Other investors ( external shareholders) | 61,80% |